Table 1.
Characteristics at baseline visit* | PD-MCI n=41 | AD-MCI n=191 | p-value |
---|---|---|---|
Number of visits, mean (SD) | 3.5 (1.5) | 3.3 (1.3) | 0.51 |
Age at baseline (years), mean (SD) | 70.2 (8.5) | 79.1 (10.3) | <.001 |
Education (years), mean (SD) | 16.0 (2.5) | 15.6 (3.1) | 0.40 |
Male, n (%) | 25 (61.0%) | 95 (49.7%) | 0.19 |
Non-white race, n (%) | 3 (7.3%) | 34 (18.0%) | 0.10 |
Age of cognitive decline onset, mean (SD) | 67.6 (9.3) | 76.5 (10.8) | <.001 |
Memory domain affected† | 26 (63.4%) | 182 (95.3%) | <.001 |
Language domain affected† | 2 (4.9%) | 29 (15.2%) | 0.13 |
Attention domain affected† | 16 (39.0%) | 16 (8.4%) | <.001 |
Executive function domain affected† | 24 (58.5%) | 65 (34.0%) | 0.003 |
Visuospatial domain affected† | 5 (12.2%) | 10 (5.2%) | 0.10 |
≥1 APOE e4 allele, n (%) | 7 (20.6%) | 64 (41.8%) | 0.02 |
Age at PD diagnosis, mean (SD) | 62.2 (9.9) | NA | NA |
Abbreviations: PD-MCI = mild cognitive impairment due to Parkinson's disease; AD-MCI = mild cognitive impairment due to Alzheimer's disease; SD = standard deviation; APOE = apolipoprotein E; PD = Parkinson's disease; NA = Not applicable
Number of participants missing data (PD-MCI, AD-MCI): Education (0,1), race (0,2), age of cognitive decline onset (0,19), APOE genotype (7,38), age of PD diagnosis (3,not applicable)
based on clinician's assessment